Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice

Journal of Autoimmunity

Volumn 37, Issue 1, 2011, Pages 39-47

  Kaminitz, Ayelet ^a,b   Yolcu, Esma S ^c   Stein, Jerry ^a   Yaniv, Isaac ^a   Shirwan, Haval ^c   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c University of Louisville School of Medicine   (United States)

Author keywords

Activation induced cell death; Fas ligand; Immunomodulation; Regulatory T cells; Type 1 diabetes

Indexed keywords

FAS LIGAND; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HOMEOSTASIS; HYPERGLYCEMIA; IMMUNOMODULATION; IN VITRO STUDY; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SUPPRESSOR CELL;

ADOPTIVE TRANSFER; ANIMALS; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; FEMALE; HOMEOSTASIS; IMMUNOMODULATION; INFLAMMATION; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES, REGULATORY;

EID: 79958022977     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.03.003     Document Type: Article

References (54)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
2. Shevach E.M. Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000, 18:423-449.
3. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27.
4. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005, 6:338-344.
5. + regulatory T cells. Immunol Rev 2006, 212:60-73.
6. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007, 13:108-116.
7. Askenasy N., Kaminitz A., Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 2008, 7:370-375.
8. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
9. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998, 10:1969-1980.
10. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296.
11. + T reg cells impinge on autoimmune diabetes. J Exp Med 2005, 202:1387-1397.
12. Pearl-Yafe M., Iskovich S., Kaminitz A., Stein J., Yaniv I., Askenasy N. Does physiological β-cell turnover initiate autoimmune diabetes in the regional lymph nodes?. Autoimmun Rev 2006, 5:338-343.
13. + T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol 2003, 171:4604-4612.
14. Grossman W.J., Verbsky J.W., Barchet W., Colonna M., Atkinson J.P., Ley T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004, 21:589-601.
15. Bryl E., Daca A., Jóźwik A., Witkowski J.M. Human CD4(low)CD25(high) regulatory T cells indiscriminately kill autologous activated T cells. Immunology 2009, 128(Suppl):e287-e295.
16. Weber S.E., Harbertson J., Godebu E., Mros G.A., Padrick R.C., Carson B.D., et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 2006, 176:4730-4739.
17. Klein L., Khazaie K., von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003, 100:8886-8891.
18. Askenasy N., Yolcu E.S., Yaniv I., Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 2005, 105:1396-1404.
19. Pearl-Yafe M., Yolcu E.S., Yaniv I., Stein J., Shirwan H., Askenasy N. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation. BioEssays 2006, 28:211-222.
20. Kaminitz A., Mizrahi K., Yaniv I., Farkas D.L., Stein J., Askenasy N. Low levels of allogeneic but not syngeneic hematopoietic chmerism reverse autoimmune insulitis in prediabetic NOD mice. J Autoimmun 2009, 33:83-91.
21. Yarkoni S., Kaminitz A., Sagiv Y., Yaniv I., Askenasy N. Targeted depletion of cells expressing the IL-2 receptor disrupts autoimmunity in prediabetic NOD mice. Diabetologia 2010, 53:356-368.
22. Askenasy N., Yolcu E.S., Shirwan H., Stein J., Yaniv I., Farkas D.L. Characterization of adhesion and viability of early seeding hematopoietic cells in the host bone marrow in vivo and in situ. Exp Hematol 2003, 31:1292-1300.
23. Yolcu E.S., Askenasy N., Singh N.P., Cherradi S.E., Shirwan H. Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity 2002, 17:795-808.
24. Iskovich S., Goldenberg-Cohen N., Stein J., Yaniv I., Farkas D.L., Askenasy N. β-Cell neogenesis: experimental considerations in adult stem cell differentiation. Stem Cells Dev 2011, 20:569-582.
25. Gregori S., Giarratana N., Smiroldo S., Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003, 171:4040-4047.
26. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004, 199:1455-1465.
27. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004, 199:1467-1477.
28. Jaeckel E., von Boehmer H., Manns M.P. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005, 54:306-310.
29. Petrovsky N., Silva D., Socha L., Slattery R., Charlton B. The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice. Ann NY Acad Sci 2002, 958:204-208.
30. Christen U., Darwiche R., Thomas H.E., Wolfe T., Rodrigo E., Chervonsky A., et al. Virally induced inflammation triggers fratricide of Fas-ligand-expressing beta-cells. Diabetes 2004, 53:591-596.
31. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., et al. Central role of defective interleukin-2 p.oduction in the triggering of islet autoimmune destruction. Immunity 2008, 28:687-697.
32. Franke D.D., Yolcu E.S., Alard P., Kosiewicz M.M., Shirwan H. A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model. Mol Immunol 2007, 44:2884-2892.
33. Tonkin D.R., He J., Barbour G., Haskins K. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J Immunol 2008, 181:4516-4522.
34. + regulatory T cells in vivo. J Exp Med 2003, 198:249-258.
35. Yarkoni S., Kaminitz A., Sagiv Y., Yaniv I., Askenasy N. Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle. BioEssays 2008, 30:875-888.
36. Yolcu E.S., Ash S., Kaminitz A., Sagiv Y., Askenasy N., Yarkoni S. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol Cell Biol 2008, 86:650-658.
37. + T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice. PLoS One 2010, 5:e15684.
38. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
39. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004, 4:665-674.
40. -CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 2005, 102:4091-4096.
41. Gavin M.A., Clarke S.R., Negrou E., Gallegos A., Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002, 3:33-41.
42. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005, 22:329-341.
43. + regulatory T cells does not inhibit the action of IL-2. Scand J Immunol 2009, 70:40-43.
44. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005, 6:1142-1151.
45. + regulatory T cells allows for their purification from expansion cultures. Blood 2009, 113:5125-5133.
46. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009, 106:1903-1908.
47. Pearl-Yafe M., Kaminitz A., Yolcu E.S., Yaniv I., Stein J., Askenasy N. Pancreatic islets under attack: cellular and molecular effectors. Curr Pharm Des 2007, 13:749-760.
48. von Herrath M., Sanda S., Herold K. Type 1 diabetes as a relapsing-remitting disease?. Nat Rev Immunol 2007, 7:988-994.
49. +CD25 high regulatory T cells in human autoimmune diabetes. J Autoimmun 2005, 24:55-62.
50. + T cells is associated with defective peripheral tolerance in non obese diabetic mice. Clin Immunol 2003, 107:103-115.
51. Decallonne B., van Etten E., Giulietti A., Casteels K., Overbergh L., Bouillon R., et al. Defect in activation induced cell death in non obese diabetic (NOD) T lymphocytes. J Autoimmun 2003, 20:219-226.
52. D'Alise A.M., Auyeung V., Feuerer M., Nishio J., Fontenot J., Benoist C., et al. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA 2008, 105:19857-19862.
53. Yolcu E.S., Gu X., Lacelle C., Zhao H., Bandura-Morgan L., Askenasy N., et al. Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein. J Immunol 2008, 181:931-939.
54. Yaniv I., Ash S., Farkas D.L., Askenasy N., Stein J. Consideration of strategies for hematopoietic cell transplantation. J Autoimmun 2009, 33:255-259.